---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-061911"
form_type: "8-K"
ticker: "CERO"
cik: "0001870404"
company_name: "CERO THERAPEUTICS HOLDINGS, INC."
filed_at: "2025-07-08T23:59:59+00:00"
generated_at: "2026-05-18T09:08:09.721475+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# CERo Therapeutics regains Nasdaq bid price compliance; delisting hearing canceled

## Summary
- On July 7, 2025, Nasdaq determined CERo regained compliance with the $1.00 minimum bid price rule.
- Company had received a deficiency notice on June 11, 2025, for 30 consecutive days of sub-$1.00 closing bid.
- CERo timely appealed the delisting determination and requested a hearing, which stayed the suspension.
- Nasdaq canceled the scheduled hearing because compliance was restored; common stock continues on Nasdaq Capital Market.
- Tickers CERO (common) and CEROW (warrants) remain listed on the Nasdaq Capital Market.

## SEC filing metadata
- accession: 0001213900-25-061911
- form_type: 8-K
- ticker: CERO
- cik: 0001870404
- company_name: CERO THERAPEUTICS HOLDINGS, INC.
- filed_at: 2025-07-08T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1870404/000121390025061911/0001213900-25-061911-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1870404/000121390025061911/ea0248316-8k_cero.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-061911
- JSON: https://secwatch.observer/filing/0001213900-25-061911.json
- Plain text: https://secwatch.observer/filing/0001213900-25-061911.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.